Uncover key drivers, emerging technologies, and competitive movements shaping the automated drug compounding systems market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the Companion Animal Veterinary Vaccines Market show for the 2026–2030 period?

The companion animal veterinary vaccines market size has shown robust growth in recent years. It is anticipated to increase from $3.94 billion in 2025 to $4.19 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.4%. The expansion observed in the past can be attributed to factors such as an increase in the companion animal population, the rising prevalence of infectious pet diseases, the growth in veterinary clinics and hospitals, enhanced awareness regarding the benefits of animal vaccination, and improvements in cold chain vaccine distribution.

The companion animal veterinary vaccines market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $5.38 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.5%. This forecasted growth is primarily driven by factors such as the growing trends of pet humanization, increased spending on pet healthcare, innovations in vaccine technology, the surge in urban pet ownership, and supportive government initiatives concerning animal health. Key developments expected during this period involve the greater uptake of combination vaccines, an enhanced emphasis on proactive pet healthcare, broader vaccination coverage for companion animals, the proliferation of recombinant and DNA-based vaccines, and an increasing preference for oral and less intrusive vaccination methods.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3370&type=smp

What Drivers Are Shaping The Development Of The Companion Animal Veterinary Vaccines Market?

The increasing spending on pet health is expected to propel the growth of the companion animal veterinary vaccines market going forward. Pet health refers to the overall well-being and condition of an animal, whether it is a dog, cat, bird, small mammal, or any other domesticated pet. The rising expenditure on pet health is due to pet owners becoming more aware of the importance of preventive care and advanced treatments to ensure their pets live longer, healthier lives. The companion animal veterinary vaccines market supports this increasing spending on pet health by providing essential vaccines that prevent diseases and reduce long-term veterinary costs, encouraging pet owners to invest more in their pets’ well-being. For instance, in February 2025, according to a report published by pet business professor, a U.S.-based government agency, U.S. pet owners spent approximately $13.42 billion on pet services, an increase of 8.5% from 2022’s $12.36 billion, reflecting sustained growth in grooming, boarding, and care utilization. Therefore, increasing spending on pet health is driving the growth of the companion animal veterinary vaccines market.

Which Segments Are Contributing To The Growth Of The Companion Animal Veterinary Vaccines Market?

The companion animal veterinary vaccines market covered in this report is segmented –

1) By Product: Inactivated, Live Attenuated, Recombinant, Other Products

2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration

3) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores, Other Distribution Channels

Subsegments:

1) By Inactivated: Inactivated Canine Vaccines, Inactivated Feline Vaccines, Inactivated Vaccine Combinations

2) By Live Attenuated: Live Attenuated Canine Vaccines, Live Attenuated Feline Vaccines, Live Attenuated Vaccine Combinations

3) By Recombinant: Recombinant Canine Vaccines, Recombinant Feline Vaccines, Recombinant Vaccine Combinations

4) By Other Products: DNA Vaccines, Subunit Vaccines, Toxoid Vaccines

What Industry Trends Are Transforming The Companion Animal Veterinary Vaccines Market?

Major companies operating in the companion animal vaccine market are introducing new vaccines, such as recombinant DNA vaccines, to improve the effectiveness and safety of immunizations for pets. A recombinant DNA vaccine is a type of vaccine created by inserting genetic material (DNA) from a pathogen, like a virus or bacterium, into a harmless organism or vector. For instance, in March 2024, Zendal Group, a Spain-based biotechnology company, launched Neoleish, which is the first recombinant DNA vaccine specifically designed to combat canine leishmaniasis, developed in collaboration with the Spanish National Research Council (CSIC). Officially presented at the XLI Annual Congress of the Madrid Association of Veterinarians of Companion Animals, Neoleish has demonstrated over 90% efficacy in reducing infection risk from the Leishmania infantum parasite.

Who Are The Primary Competitors In The Global Companion Animal Veterinary Vaccines Market?

Major companies operating in the companion animal veterinary vaccines market are C.H. Boehringer Sohn AG & Co. KG, Heska Corp., Merck and Co. Inc., Elanco Animal Health, Zoetis Inc., Ceva Sante Animale SA, Vetoquinol SA, Hipra India Pvt Ltd, Bimeda Animal Health Limited, Nexvet Biopharma plc, Laboratorios Hipra SA, Dechra Pharmaceuticals PLC, CZ Veterinaria SA, Virbac, Boehringer Ingelheim Animal Health, Indian Immunologicals Limited, HIPRA SA, IDT Biologika GmbH, Ourofino Saude Animal, Zydus Animal Health, Meiji Seika Pharma Co Ltd, Parnell Pharmaceuticals, Kindred Biosciences Inc, Hester Biosciences Limited

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/companion-animal-veterinary-vaccines-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Companion Animal Veterinary Vaccines Market?

North America was the largest region in the companion animal veterinary vaccines market in 2025. Asia-Pacific was the second-largest region in the companion animal veterinary vaccines market. The regions covered in the companion animal veterinary vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Companion Animal Veterinary Vaccines Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=3370&type=smp

Browse Through More Reports Similar to the Global Companion Animal Veterinary Vaccines Market 2026, By The Business Research Company

Veterinary Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Dog Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/dog-vaccines-global-market-report

Veterinary Antibiotics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-antibiotics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company